Comparative effectiveness and safety of apixaban and rivaroxaban in cirrhosis and atrial fibrillation

被引：0
|
作者：
Simon, Tracey G. [1 ]
Zhang, Yichi [2 ]
Mastrorilli, Julianna [3 ]
Cervone, Alexander [3 ]
Lin, Kueiyu Joshua [2 ]
机构：
[1] Massachusetts Gen Hosp, Boston, MA USA
[2] Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, Boston, MA USA
[3] Brigham & Womens Hosp, Boston, MA USA
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2023年 / 32卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
143
引用
收藏
页码：56 / 57
页数：2
相关论文
共 50 条
  • [1] Comparative Effectiveness and Safety of Apixaban, Rivaroxaban, and Warfarin in Patients With Cirrhosis and Atrial Fibrillation: A Nationwide Cohort Study
    Simon, Tracey G.
    Singer, Daniel E.
    Zhang, Yichi
    Mastrorilli, Julianna M.
    Cervone, Alexander
    DiCesare, Elyse
    Lin, Kueiyu Joshua
    ANNALS OF INTERNAL MEDICINE, 2024, 177 (08)
  • [2] Effectiveness and Safety of Apixaban Versus Rivaroxaban for Patients With Atrial Fibrillation
    不详
    ANNALS OF INTERNAL MEDICINE, 2020, 172 (07) : 463 - 473
  • [3] Comparative effectiveness and safety of apixaban, dabigatran, and rivaroxaban in patients with non-valvular atrial fibrillation
    Andersson, Niklas W.
    Svanstrom, Henrik
    Lund, Marie
    Pasternak, Bjorn
    Melbye, Mads
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2018, 268 : 113 - 119
  • [4] Comparative Effectiveness of Rivaroxaban, Apixaban, and Warfarin in Atrial Fibrillation Patients With Polypharmacy
    Mentias, Amgad
    Heller, Eric
    Vaughan Sarrazin, Mary
    STROKE, 2020, 51 (07) : 2076 - 2086
  • [5] DIRECT COMPARISON OF DABIGATRAN, RIVAROXABAN, AND APIXABAN FOR EFFECTIVENESS AND SAFETY IN NONVALVULAR ATRIAL FIBRILLATION
    Noseworthy, Peter
    Yao, Xiaoxi
    Sangaralingham, Lindsey R.
    Abraham, Neena
    McBane, Robert
    Gersh, Bernard
    Shah, Nilay
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 67 (13) : 692 - 692
  • [6] Direct Comparison of Dabigatran, Rivaroxaban, and Apixaban for Effectiveness and Safety in Nonvalvular Atrial Fibrillation
    Noseworthy, Peter A.
    Yao, Xiaoxi
    Abraham, Neena S.
    Sangaralingham, Lindsey R.
    McBane, Robert D.
    Shah, Nilay D.
    CHEST, 2016, 150 (06) : 1302 - 1312
  • [7] Direct comparisons of effectiveness and safety of treatment with Apixaban, Dabigatran and Rivaroxaban in atrial fibrillation
    Jansson, M.
    Sjalander, S.
    Sjogren, V.
    Renlund, H.
    Norrving, B.
    Sjalander, A.
    THROMBOSIS RESEARCH, 2020, 185 : 135 - 141
  • [8] Effectiveness and Safety of Dabigatran, Rivaroxaban, and Apixaban Versus Warfarin in Nonvalvular Atrial Fibrillation
    Yao, Xiaoxi
    Abraham, Neena S.
    Sangaralingham, Lindsey R.
    Bellolio, M. Fernanda
    McBane, Robert D.
    Shah, Nilay D.
    Noseworthy, Peter A.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2016, 5 (06):
  • [9] Safety of apixaban and rivaroxaban in patients with atrial fibrillation on hemodialysis
    Ito, Hiroshi
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2024, 124 : 154 - 155
  • [10] Comparative effectiveness and safety of apixaban and rivaroxaban in older patients with atrial fibrillation: A population-based cohort study
    Shurrab, Mohammed
    Austin, Peter C.
    Jackevicius, Cynthia A.
    Tu, Karen
    Qiu, Feng
    Haldenby, Olivia
    Middleton, Allan
    Turakhia, Mintu P.
    Lopes, Renato D.
    Boden, William E.
    Castellucci, Lana A.
    Heidenreich, Paul A.
    Healey, Jeff S.
    Ko, Dennis T.
    HEART RHYTHM, 2024, 21 (12) : 2397 - 2406
12345